Chari
Number 1007819
THE RALPH BATES PANCREATIC CANCER RESEARCH FUND
UNAUDITED ANNUAL REPORT AND FINANCIALSTATEMENTS
FOR THE YEAR ENDED
315T MARCH 2023

THE RALPH BATES PANCREATIC CANCER RESEARCH FUND
Chari
no: 1007819
CONTENTS
PAGE I
CONSTITUTION, TRUSTEES AND ADVISORS
PAGE2-3
TRUSTEES'REPORT
PAGE4
INDEPENDENT EXAMINER'S REPORT
PAGE 5
STATEMENT OF FINANCIAL ACTIVITIES
PAGE 6
BALANCE SHEET
PAGE 7- 10
NOTES TO THE FINANCIAL STATEMENTS

THE RALPH BATES PANCREATIC CANCER RESEARCH FUND
Char
No: 1007819
PAGE I
CONSTITUTION
The Ralph Bates Pancreatic Cancer Research Fund is a Registered Charity, No. 1007819 and
was formed on 17 January 1992. The fund is governed by a Trust Deed and managed by the
Trustees.
PATRON AND TRusfEE
SIR PETER BLAKE. C8E. RDI.RA
TRUSTEES
Mrs. Vir8inia Bates
Dr John Glees MD, FRCR
Mr Michael Bridge FCA
Mrs. Sharon Sullivan
Mr. Nigel Baly. Bsc. MRICS
Mr. Les Biggs ACIS (Secretary}
BANKER
HSBC Bank PLC, 9 Hlgh Street. Ketterln& Northants, NN16 8ST
INDEPENDEprf EXAMINER
Mr C W Soper FCCA, 20 Furzen Close, Dunstable.Beds.LU6 3EN
LEGAL ADVISERS
Edwin Coe, 3 Stone Building5, Llncolns Inn. London. WC2 3TH
REGISTERED ADDRESS
St Georges University of London. Jenner Wing, CranmerTerrace, London, SW170RE
ADMINISTRATION ADDRESS
317 Old Bedford Road, Luton. Beds. LU2 78L

THE RALPH 8ATES PANCREATIC CANCER RESEARCH FUND
Char
No:1007819
PAGE 2
TRUSTEES, REPORT
The Trustees are pleased to present their report for the year ended 31 March 2023.
OBJEcfivES AND ORGANISATION OF THE CHARITY
The Charity was constituted under a Trust Deed dated 17 January 1992, the principal
objectives of which are:
"Both capital and Income of the Fund shall be applied by the Trustees for all or any of the
following purposes:.
al To promote research into pancreatic can￿r and associated diseases, dlsabilities and
conditions by way of grant. remuneration, loans, or other assistance for persons,
hospitals, universities, colleges, institutions, corporate bodies, charities, trust or
other engaged in such research.
bl To carry out or participate in such research directly.
cl To provide relief and comfort for pancreotic cancer sufferers either directly or
through any hospital. charity, instltution or other party engaged in such work.
d) To establish, endow, fund or asslst fellowship bursaries or scholarships linked with
the name Ralph Bates and tenable by persons en8aged wholly or malnly In
pancreatic cancer research or treatment.
The Trustees who served in the year are set out on Pa8e l of the financial statements. There
are no subcommittees. The existing Board of Trustees is responsible for appointing other
Trustees. When considering candidates, the Trustees take into account any profe551onal
qualifications, clinical OT Other relevant experience and the ¢3ndidate's Potential
contribution to the Charity.
The Trustees have been mindful of, and ensured that, the Charity ha5 acted in accordan
with the Charity Commission's guidante as pertains to public benefit.
REVIEW OF AcrivmES ACHlEVEMEP￿s AND FUTURE PLANS
Research work at St George's Unlver5ity of London gradually returned to normal after the
Coronavirus pandemic. Unfortunately. one of our key research assistants moved to Bath
University to complete her PhD, but the team continued under the dlrert control of our
Research Leader. A replacement started with us in April 2023.
As we mentloned last year, the Team had some encouraging results when pancreatic ce115
were treated with a combination of various dru8s. including gemcitabine Ithe usual
treatment) and research work in thi5 field continues.
Donations have picked up from the period affected by covid but wirh contlnuing tight
ontrol of expenses. we feel able to continue this important research.
During this financial year, we participated in an appeal for funds to support research at
Oxford University. The donations received are restrirted to research being carried out by
specific team and were made in memory of Richard Nevill, who was undergoing private
treatment for pancreatic cancer administered by this team. Unfortunately, he died during
the appeal. but the Oxford Team will continue their research funded by donations made in
Richard's name.

THE RALPH BATES PANCREATIC CANCER RESEARCH FUND
Char
No:1007819
PAGE 2A
TRUSTEES, REpoKf- Continued.
In April 2023, as stated above, a new research assistant was appointed and a new
agreement with St. Georges wa5 commenced. The agreement last5 for three years from
April 1ST 2023 and is for a total cost of £90,LX)3.
FINANCIAL REVIEW
During the year donation5 and other income amounted to £70,435 12022 £26.9231 and
expenditure was £5,463 12022 - £2,359) leaving a Surplus of £64,97212022
surplus of
£24,564), which is transferred to the Unrestricted Funds brought forward which stand at
£46,557 and restricted £54,664, totaling £101,22112022- £36,249).
After making appropriate enquirie5 the Trustees have a reasonable expectation that the
Charity has adequate resources to continue in operational existence for the foreseeable
future. Thls includes consideration of the impact of COVID-19. Fundraising traditionally
varies from year to year but has been affected by COVID-19 howeveT It is too early to
determine the lon8er term impact on fund rai5in8. The pTinclple Item of expen¢Jiture 15 the
funding of research whlch has itself been affected by COVID-19 and has delayed costs. Even
If the Charity received no further income Iwhich the Trustees regard as m05t unlikelvl the
Charity can sustain a comparable level of activity for the next two years at least. For this
reason, they contlnue to adopt the 80ing concem basi5 In preparlng the financlal
statement5.
The Trustees recogn12e that whilst there is some uncertainty, there is not deemed to be a
materlal uncertainty on the charitvs ability to continue as a going concern.

THE RALPH BATES PANCREATIC CANCER RESEARCH FUND
Char
No:1007819
PAGE 3
TRUSTEES, REPORT- Continued.
RESERVES POLICY
The Trustees attempt to retain income and reserves to enable the funding
known and potential expenditure of future research into pancreatic cancer and associated
diseases, disabilitie5 and conditions.
RISK MANAGEMENT
The Trustee5 have assessed the major risks to which the Charity is exposed, In partlcular
those related to the operations and finances of the Charity, and are satisfied that systems
and procedures are in place to mitigate the Charity's exposure to the major risks. Thls
Includes consideration in 2022-2023 and 2021-2022 of the impart of COVIDI9.
Si8ne
ol the Board
L R BIGGS- Trustee
Dated: 11 SLfYLH7>cL Zoz3

THE RALPH BATES PANCREATIC CANCER RESEARCH FUND
Char
No:l(M17819
PAGE 4
INDEPENDENT EXAMINERS REPORT
I report to the trustees on my examination of the accounts of the Charty for the year ended
31 March 2023, which are set out on pages 5 to 10.
This report is made solely to the Charitys Trustees, as a body. in accordance with Regulation
31 of the Charities IAccounts and Reports) Regulations 2008. My work has been undertaken
so that I mi8ht state to the Charitys Trustees those matters l am required to state to them
in an Independent Examinerfs report and for no other purpose. To the fullest extent
permitted by law. I do not accept responsibility to anyone other than the Charitys Trustees
as a body, for my work, for this report. or the statement I have made.
RESPONSIBIUTIESAND BASIS OF REPORT
As the Charity Trustees you are responsible for the preparatlon of the accounts In
accordance with the requirements of the Charities Att 20111.the Acr").
I report in respect of my examlnation of the Charit¢s Accounts carried out under section
145 of the 2011 Act and in carrying out my examination I have followed all applicable
DSrectlons given by the Charity Commission under section 14515llbl of the Art.
INDEPENDENT EXAMINEWS STATEMENT
I have completed my examination. I confirm that no materlal matter5 have come to my
attentlon in connection with the examinatlon 8lving me cause to belleve:
al Accountln8 record5 were not kept in respect of the Charity as require by sectlon 130
of the Act,. or
bl The account5 do not accord with those records,, or
cl The accounts do not comply with the accounting requirements concerning the form
and content of the accounts set out in the Charities IA¢counts and Reportsl
Regulation5 2008 other than any requirement that the accounts give a 'true and fair
view which is not a matter considered as part of an Independent examination; or
dl The actounts have not been prepared in accordance with the methods and principles
of the Statement of Recommended Practice for accounting and reportSng charities
applicable to charities preparing their accounts in accordance with the Financial
Reportin8 Standard applicable in the UK and the Republic of Ireland IFRS1021.
I have no concerns and have come across no other matters In connection with the
examlnation to which attention should be drawn in this report in order to enable a proper
understandln8 of the account5 to be reached.
C W SOPER FCCA
Chartered Certified Accountant
20 Furzen Close
Dunstable
LU6 3EN
Dated.. K2 S fTrikLkn2S

RALPH BATES PANCREATIC CANCER RESEARCH FUND
Cha
No:1007819
PAGE 5
FINANCIAL AcfiviTIES FOR THE YEAR ENDED 31st MARCH 2023
As Restrjted
Total
Fund5
2022
Unrestrirt Restricted
Funds
Funds
2023
2023
Total
Funds
2023
INCOME FROM
Donatlons and Legacies I Inc Gift Aid)
Investment Income
£15,014 £55,163
£191
£67
£70,177
£258
£26,911
£12
TOTAL
£15,205 £55,230
£70,435
£26,923
EXPENDITURE ON
RaisSn8 Funds
Charltable Activities
£2.940
£1.958
£566
£3,505
£1,958
£1,510
£849
TOTAL
£4,897
£566
£5,463
£2,359
NEf INCOMEIEXPENDMJRE
£10,308 £54,664
£64,972
£24,564
FUNDS BALANCE5 8IFwd
£36,249
£36,249
£11,685
FUNDS BALANCES CIFwd
£46,557 £54,664
£101,221
E36,249
All amounts derive from continuing activities.
The statement of flnancial activities includes all gains and10sses reco8nised in the year.

RALPH BATES PANCREATIC CANCER RESEARCH FUND
Chari
No:1007819
PAGE 6
BALANCE SHEET AS AT 31 MARCH 2023
Note
2023
2023
2022
2022
CURRENT ASSErs
Debtors
Cash at Bank and in Hand
£2,926
£110.786
£2,831
£65,413
£113,71Z
£68,244
CREDITORS
Amounts Falling due within one Year
£12,491
£31,995
NFf CURRENT ASSErs
£101,221
£36,249
Amounts Falling due after more than one yea
£0
£0
NET AssErs
£101,221
£36,249
Represented bv:
UNRESTRicfED FUN05
RESTRICTED FUNDS
io
io
£46,058
£55,163
£101,221
£36,249
£0
£36,249
The financial statements were approved and authorised for issue by the Trustees on:
V Bates..
..Chairperson
L R Biggs........,............
-.Trustee

THE RALPH BATES PANCREATIC CANCER RESEARCH FUND
Char
No:1007819
PAGE 7
NOTES TO THE ACCOUNTS
I. ACCOUNTING POUCIES
lal The Charity is registered In England and Wales. The financial Statements have been
prepared under the historical basis. The financial statements have been prepared in
accordance with the Charities Act 2011. the Statement of Recommended Practice
applicable to the charities preparing their accounts in accordance with the Financial
Reporting Standard applicable in the UK and the Republic of Ireland I the FRS 102
Charities SORPI.
The charity constitutes a public beneflt entity as deflned by FRS 102.
The financlal statements are presented in sterling and are rounded to the nearest
pound.
The financial statements have been prepared to give a 'true and fairf view and have
departed from the Charities (Accounts and Reports) Regulations 2008 only to the
extent required to provide a 'true and fairf view. Thls departure ha5 involved
following the Charities SORP IFRS 1021 publlshed l January 2019 rather than the
Accounting and Reporting by Charities.. Statement of Recommended Practlce
effective from l April 2005 which has been withdrawn.
Ibl Goin8 Concem
The Trustees confirm that at the time of approving the flnancial
Statements, there are no material uncertainties regarding the Charity's ability to
contlnue in operational existence for the foreseeable future. In arrlving at this
conclusion, The Trustees have taken account of current and antlcipated flnancial
performance in the current economic conditlons, its Corporate Plan and its reserves
position as referred in the Trustees report.
Icl Donations are included in the statement of financial activities when received, except
donations from sponsorship of events whlch are accounted in the year In which the
event takes plate. Bank interest is included in the statement of flnan¢ial actlvitles on
the basls of the amount receivable in respect of each financial year.
Idl Expenditure is included in the financial statements when incurred, except costs
related to fund raising events whlch are accounted for in the year in which the event
takes place. Grants for research are included when a legal obligation arises.
lel Restritted funds comprise monies received subject to specific condltions required by
the donor and bindin8 on the Trustees and relate to a specific research project,
Unrestricted funds are made up of all other donations and interest and are for
general use.
lfj The charity only has financial assets and liabilities that qualify as basic financial
Instruments. Basic financial instrument5 are initially recognized at transaction value
and subsequently measured at their settlement value.
181 Short term debtors are measured at tran5artion price, less any impairment. Loans
receivable are measured Initially at a fair value, net of transaction costs, and are
measured subsequently at amortized cost using the effertlve interest method, less
any impalmient.

THE RALPH BATES PANCREATIC CANCER RESEARCH FUND
Char
No:1007819
PAGE 8
NOTES TOTHE ACCOUNTS
Continued
Ihl Cash is represented by cash in hand and deposits with financial institutions
repayable without penalty on notice of not more than 24 hours. Cash equivalents
are highly liquld investments that mature in no more than three months from the
date of acquisition and that are readily convertible to known amounts of cash withln
significant risk of change of value.
lil Short term creditors are measured at the transaction price. Other financial liabilitie5
including bank loans are measured inttially at fair value, net of transattlon costs, and
are measured subsequently at amortized cost using the effective interest method.
2. JUDGEMENTS IN APPLYING THE ACCOUNTING POLICIES AND KEY SOURCES OF
ESTIMATION UNCERTAINTY.
In the application of the trusvs accountlng pollcles, the trustee5 are require to make
Judgments, estimates and assumptions about the carrying amounts of assets and
liabilities that are not readily apparent from other sources. The estimates and
associated assumptions are based on historical experience and other factors that are
considered to be relevant. Actual results may differ from these estimates.
The estimates and underlylng assumptions are reviewed on an ongoing basis.
Revisions to accountin8 estimates are reco8nized in the period in which the estimate
Is revised if the revislon affects only that period or in the period of the revision and
future perlods if the revision affects both current and future perlods.
There were no judgement or material estimation uncertsinties affectlng the
reported financial performance in the current or prior year.
3. REMUNERATION AND EXPENSES OF THE TRusfEES.
None of the Trustees recelved any remuneration for their services or reimbursement
for expenses Incurred during the year.12022 - Enlll.
4.EMPLOYEES
The charity does not employ any staff. During the year there were 7 Trustees12022- 71.

THE RALPH BATES PANCREATIC CANCER RESEARCH FUND
No:1007819
PAGE 9
NOTES TO THE ACC
ufrThs
Contlnued
S. RESOURCES EXPENDED
Unrestricted
Funds
2023
2022
Ex￿ndItUre on Raising Funds
Webslte, onllne a8ency costs. event
Entry costs and commissions
2,515
1.536
Expenditure on Charitable Activities
Research studentship and tuition fees at:
St Geor8e's University of London
Imperial College London
1,958
Independent Examiners Fees
500
521
Printlng, Postage , Stationery,
Telephone and Miscellaneous Items
490
301
5,463
2,358

RALPH BATES PANCREATIC CANCER RESEARCH FUND
Chari
No:1007819
PAGE 10
Notes formln8 Part of the Flnanclal Statements
foi the Year Ended 31 March 2022-1 Contlnuedl
6 DEBTORS
2023
Gift Aid Receivable
Prepaid Expenses
Stocks
2022
1,909
£922
£2.926
£2,926
E2.&31
7 CASH AND CASH EqUIVALeNT5
2023
2022
Cash at Bank and In Hand
£120.786
£65,413
8 CREDITORS: AMOUNTS FALU14G DUE WITHIN thYE YEAR
2023
2022
Ac¢ru4ls
Other Credltors
£500
£11,991
£s
£31,495
£12,491
£31995
9 CREDITORS.. AMOUNTS FALLING WE AFTER MORE THAN ONE YEAR
202J
2022
Other Credltors
10 FUNDS
2023
2022
Unrestrlcted
Rèstrltted
£46.058
£55,163
£101221
£36.249
£36,249